https://ipharmag.com/article/slate-fulcrum-reverse-merger-migraine-pacap iPharmag en 2026-08-18T03:43:14+00:00 Fulcrum Pivots to Migraine, Merging With Slate to Chase a New Drug Target https://ipharmag.com/article/malaria-chemovaccination-mosquito-bites-immunity iPharmag en 2026-08-18T03:43:14+00:00 Turning Mosquito Bites Into Vaccinations: A New Malaria Strategy Protects Mice https://ipharmag.com/article/eyepoint-durayvu-wet-amd-trial-miss iPharmag en 2026-08-18T03:43:14+00:00 EyePoint Shares Crater 70% After Eye Drug Misses in Pivotal Wet AMD Trial https://ipharmag.com/article/argenx-vyvgart-myositis-phase-3-alkivia iPharmag en 2026-08-18T03:43:14+00:00 Argenx’s Vyvgart Succeeds in Myositis Trial, Opening a New Front for the Blockbuster https://ipharmag.com/article/albumin-fused-antibodies-reduce-fetal-drug-exposure iPharmag en 2026-08-18T03:43:14+00:00 A Redesigned Antibody Could Let Pregnant Patients Take Biologic Drugs More Safely https://ipharmag.com/article/sandoz-henlius-322m-biosimilar-deal iPharmag en 2026-08-17T15:17:22+00:00 Sandoz Bets on Biosimilars, Adding Up to 10 From Henlius in a $322M Deal https://ipharmag.com/article/pfizer-valneva-lyme-disease-vaccine-ema-validation iPharmag en 2026-08-17T15:17:22+00:00 EMA Begins Review of Pfizer and Valneva’s Lyme Disease Vaccine, a Potential First https://ipharmag.com/article/malaria-plasmodium-uganda-drug-resistance-px1 iPharmag en 2026-08-17T15:17:22+00:00 Malaria Parasites in Uganda Are Rapidly Spreading Drug-Resistance Mutations, Study Warns https://ipharmag.com/article/lantheus-tauklarify-tau-pet-alzheimers-fda-approval iPharmag en 2026-08-17T15:17:22+00:00 FDA Approves Lantheus’s Tauklarify, a Brain-Scan Agent That Maps Alzheimer’s Tau Tangles https://ipharmag.com/article/breast-cancer-nerve-network-bdnf-macrophages iPharmag en 2026-08-17T15:17:22+00:00 How Aggressive Breast Cancer Wires Itself Into the Nervous System — and a Drug That Might Cut the Cord https://ipharmag.com/article/why-walking-harder-with-age-ankle iPharmag en 2026-08-17T03:53:15+00:00 Why Walking Gets Harder With Age: Stiffer Ankles Trade Efficiency for Stability https://ipharmag.com/article/vogenx-ipo-post-bariatric-hypoglycemia-mizagliflozin iPharmag en 2026-08-17T03:53:15+00:00 Vogenx Raises $81M in IPO to Tackle a Little-Known Side Effect of Weight-Loss Surgery https://ipharmag.com/article/midlife-exercise-blood-sugar-cognitive-decline iPharmag en 2026-08-17T03:53:15+00:00 Staying Active and Keeping Blood Sugar in Check at Midlife Linked to Slower Cognitive Decline https://ipharmag.com/article/low-dose-digoxin-heart-failure-hospitalizations iPharmag en 2026-08-17T03:53:15+00:00 A Century-Old, 10-Cent Heart Drug Cut Hospitalizations by a Quarter in New Trial